These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 21942257)

  • 21. Customizing inhaled therapy to meet the needs of COPD patients.
    Fromer L; Goodwin E; Walsh J
    Postgrad Med; 2010 Mar; 122(2):83-93. PubMed ID: 20203459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cosuspensions of microcrystals and engineered microparticles for uniform and efficient delivery of respiratory therapeutics from pressurized metered dose inhalers.
    Vehring R; Lechuga-Ballesteros D; Joshi V; Noga B; Dwivedi SK
    Langmuir; 2012 Oct; 28(42):15015-23. PubMed ID: 22985189
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Multiple dose devices = positive].
    Krankenpfl J; 2005; 43(7-10):264. PubMed ID: 16515334
    [No Abstract]   [Full Text] [Related]  

  • 24. Inappropriate techniques used by internal medicine residents with three kinds of inhalers (a metered dose inhaler, Diskus, and Turbuhaler): changes after a single teaching session.
    Kim SH; Kwak HJ; Kim TB; Chang YS; Jeong JW; Kim CW; Yoon HJ; Jee YK
    J Asthma; 2009 Nov; 46(9):944-50. PubMed ID: 19905924
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel formulation technique for metered dose inhaler (MDI) suspensions.
    Steckel H; Wehle S
    Int J Pharm; 2004 Oct; 284(1-2):75-82. PubMed ID: 15454299
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Principles of nebulizer-delivered drug therapy for asthma.
    Johnson CE
    Am J Hosp Pharm; 1989 Sep; 46(9):1845-55. PubMed ID: 2679064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Challenges and opportunities in respiratory drug delivery devices.
    Nikander K
    Expert Opin Drug Deliv; 2010 Nov; 7(11):1235-8. PubMed ID: 20939686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhalation therapy with metered-dose inhalers and dry powder inhalers in mechanically ventilated patients.
    Dhand R
    Respir Care; 2005 Oct; 50(10):1331-4; discussion 1344-5. PubMed ID: 16185369
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Inhaled corticosteroid therapy in mild and moderate persistent asthma. Acceptability of a new inhalation system: the jet].
    Pujet JC; Allaert FA; Lefrançois G; Umile A
    Rev Pneumol Clin; 1999 Apr; 55(2):88-93. PubMed ID: 10418052
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of metered-dose inhalers in hospital environments.
    Vargas O; Martinez J; Ibanez M; Pena C; Santamaria M
    J Aerosol Med Pulm Drug Deliv; 2013 Oct; 26(5):287-96. PubMed ID: 23458577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Economics of "essential use exemptions" for metered-dose inhalers under the Montreal Protocol.
    DeCanio SJ; Norman CS
    J Environ Manage; 2007 Oct; 85(1):1-8. PubMed ID: 16982135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metered-dose inhaler technique per the Global Initiative for Asthma and Expert Panel Report 3: Why do pharmaceutical companies have one critical difference?
    Self TH; Hoth LM; Bolin JM; Stewart C
    Ann Allergy Asthma Immunol; 2016 Jul; 117(1):101-2. PubMed ID: 27221064
    [No Abstract]   [Full Text] [Related]  

  • 33. Pressurized Metered Dose Inhaler Technology: Manufacturing.
    Vallorz E; Sheth P; Myrdal P
    AAPS PharmSciTech; 2019 Apr; 20(5):177. PubMed ID: 31037395
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genuair(®) in chronic obstructive pulmonary disease: a novel, user-friendly, multidose, dry-powder inhaler.
    der Palen Jv
    Ther Deliv; 2014 Jul; 5(7):795-806. PubMed ID: 25287386
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Approaches to improving therapeutic success].
    MMW Fortschr Med; 2014 Jun; 156(12):62-3. PubMed ID: 25369691
    [No Abstract]   [Full Text] [Related]  

  • 36. The US and EU regulatory landscapes for locally acting generic/hybrid inhalation products intended for treatment of asthma and COPD.
    Fuglsang A
    J Aerosol Med Pulm Drug Deliv; 2012 Aug; 25(4):243-7. PubMed ID: 22857274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Challenges and opportunities for combination therapy in chronic obstructive pulmonary disease.
    Rennard SI; Stoner JA
    Proc Am Thorac Soc; 2005; 2(4):391-3; discussion 394-5. PubMed ID: 16267368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Six-month in vitro validation of a metered-dose inhaler electronic monitoring device: implications for asthma clinical trial use.
    Patel M; Pilcher J; Chan A; Perrin K; Black P; Beasley R
    J Allergy Clin Immunol; 2012 Dec; 130(6):1420-2. PubMed ID: 22920492
    [No Abstract]   [Full Text] [Related]  

  • 39. The COPD pipeline VIII.
    Gross NJ
    COPD; 2011 Feb; 8(1):52-4. PubMed ID: 21299478
    [No Abstract]   [Full Text] [Related]  

  • 40. Is your patient's metered-dose inhaler technique up to snuff?
    Bower LM
    Nursing; 2005 Aug; 35(8):50-1. PubMed ID: 16062144
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.